AminoVault Appears in 7.3% of AI Answers. Here's Our Five-Step Plan to Improve Its AI Visibility.
This report supports CiteWorks Studio's examination of how AI search is recommending Peptide Suppliers. For more detail, you can also read Peptide Suppliers: AI Visibility Discovery Index.
On this report
Browse sections
- Answer Capsule
- Current AI visibility
- What changed since last month
- Next Step
- Step 1. Measure
- Step 2. Make the website consistent
- Step 3. Align the external narrative
- Step 4. Optimize priority company pages
- Step 5. Publish around buyer questions
- Our 90-day action plan
- Methodology
- Our first three priorities
- Related research
- Learn More
Key Takeaways
- AminoVault is mentioned in a modest share of benchmark answers, but recommendations are usually positive when it appears.
- The main issue is reach, not reputation, since the brand is rarely framed negatively and often sits outside the top three.
- The homepage carries most of the company’s citations, so it is the first priority for page updates.
- Buyer questions center on supplier choice, US-based research peptides, and reputation, which gives clear topics for new content briefs.
Answer Capsule
In November 2026, AminoVault appeared in 33 of 453 AI answers included in the Peptide Suppliers benchmark (7.28%). It received 27 recommendations (5.96%), with 17 Top 3 placements and 5 first-place recommendations. A mention means the company appeared in an answer; a recommendation means the answer affirmatively endorsed it.
Our plan compares the company with its competitors, checks conflicting AI claims against reliable sources, and identifies website pages, third-party sources and buyer questions to address. This edition establishes a research baseline. It does not claim a change from earlier editions measured on a different basis. Conflicting AI claims require verification before corrections are proposed.
Current AI visibility
Questions This Section Answers
- How do AminoVault mentions, recommendations and placements compare with its Peptide Suppliers peers?
AminoVault recorded 33 mentions (7.28%) and 27 recommendations (5.96%) across 453 answers included in the benchmark. Top 3 placements numbered 17; first-place recommendations numbered 5. Framing among its mentions was 27 positive, 6 neutral and 0 negative.
Rank | Company | Mentions | Mention rate | Recommendations | Recommendation rate | Top 3 | Top 3 rate | #1 | #1 rate |
|---|---|---|---|---|---|---|---|---|---|
1 | Phoenix Pharmaceuticals | 178 | 39.29% | 117 | 25.83% | 94 | 20.75% | 58 | 12.80% |
2 | Biotech Peptides | 142 | 31.35% | 91 | 20.09% | 70 | 15.45% | 28 | 6.18% |
3 | Core Peptides | 152 | 33.55% | 72 | 15.89% | 59 | 13.02% | 17 | 3.75% |
4 | AminoVault | 33 | 7.28% | 27 | 5.96% | 17 | 3.75% | 5 | 1.10% |
5 | Peptides Source | 10 | 2.21% | 4 | 0.88% | 3 | 0.66% | 1 | 0.22% |
6 | Blue Sky Peptide | 36 | 7.95% | 3 | 0.66% | 3 | 0.66% | 0 | 0.00% |
7 | Peptide Tech | 7 | 1.55% | 0 | 0.00% | 0 | 0.00% | 0 | 0.00% |
AminoVault appears in a modest share of benchmark answers, but when it appears it is usually endorsed and almost never framed negatively. That combination suggests the brand is credible to the answering systems yet rarely reaches the shortlist. The gap to the leading suppliers is therefore about reach, not reputation.
Placement is thinner still. Most of its recommendations sit outside the top three, and first-place finishes are rare. The agency would treat this as a reach problem first: broaden the questions and sources where AminoVault is considered before chasing higher placement within answers it already enters.
Because this edition sets a new baseline, these figures describe one selected sample rather than a trend. The agency would pair the visibility scorecard with a fact-check list so any content work rests on verified claims rather than assumptions about why the brand is absent.
What changed since last month
Questions This Section Answers
- How did AminoVault counts and coverage differ across the available monthly snapshots?
Metric | Nov 2026 |
|---|---|
Mentions | 33 / 453 (7.28%) |
Recommendations | 27 / 453 (5.96%) |
Top 3 recommendations | 17 / 453 (3.75%) |
#1 recommendations | 5 / 453 (1.10%) |
Only months with verified results are shown. Monthly sample coverage is listed in Methodology.
This edition establishes a broader research baseline. Earlier editions used a narrower set of questions, so their figures are not treated as a performance trend.
This edition is the first broad baseline, so the monthly figures should be read as a starting reference rather than a movement from earlier editions. Earlier editions asked a narrower set of questions, which makes direct comparison unsafe. The agency would label this month as the anchor for future comparison.
That means no claim of improvement or decline is warranted yet. The useful question is what the next edition with the same question scope shows. The agency would keep the baseline scorecard stable and record any changes in question coverage alongside it, so later movement can be attributed to the market rather than to a changed sample.
AI recommendation trend
Observed recommendation rate (%), Nov 2026
- AminoVaultno changeNov 20265.96%
Separate selected monthly samples. Missing points are unavailable, not zero. Provider/prompt equivalence is unverified; rate movement does not demonstrate causation.
/ Take the next step
Want to Understand Your AI Citation Footprint?
We start every engagement with a full audit of how AI systems reference your brand today.
Measurable, Repeatable Programme
Build a durable foundation of credible citations that compounds over time and continues to influence AI answers as new queries emerge
Citation Architecture Review
Identify which high-authority community sources are and aren't working in your favour across AI platforms.
AI Visibility Audit
Understand exactly how LLMs are referencing your brand today and which sources are shaping those answers.
Step 1. Measure
Questions This Section Answers
- What should the agency measure and verify first for AminoVault?
AI answers contained 0 conflicting claims about AminoVault: 0 critical, 0 high, 0 medium, 0 low. Of these, 0 were rated critical or high priority; the critical claims are included in that total. These ratings help prioritize fact-checking. They do not establish that a company or publisher made an error.
No conflicting claims about AminoVault were recorded in the captured answers, so there is nothing urgent to correct. That is a clean starting position, but it is not proof that every statement about the company is accurate. The agency would still build a short fact-review list from the claims that do appear.
A visibility comparison against the leading suppliers would show where AminoVault is considered and where it is overlooked. Pairing that with the fact list lets the client prioritize reach-building on questions where the brand is credible, while confirming the claims that answering systems repeat.
Step 2. Make the website consistent
Questions This Section Answers
- Which recorded claim differences about AminoVault should be verified before proposed page edits?
No results are available for this part of the analysis.
Both columns quote AI answers, not verified company facts. Resolve the entity, date and source before deciding whether a correction is warranted; different dates can explain an apparent conflict.
No disputed topics were supplied for this part of the analysis, so there is no claim to adjudicate this month. The agency would not invent conflicts to fill the gap. Instead it would confirm the company's core facts, such as identity, product scope and sourcing language, against primary sources.
Where an apparent conflict surfaces later, the first step is to resolve the entity, date and source before deciding whether a correction is warranted. Different dates can explain an apparent disagreement. Page briefs would then be drafted only for confirmed gaps, and only after the client approves the underlying facts.
Step 3. Align the external narrative
Questions This Section Answers
- Which cited third-party pages are relevant to fact review for AminoVault?
Cited page selected for review | Citation appearances in all captured answers | Answers mentioning the company | Conflicting claims linked to this page |
|---|---|---|---|
https://onetwenty.com/blog/peptide-companies | 77 | 13 | 0 |
https://phoenixpeptide.com/ | 91 | 11 | 0 |
https://biosynth.com/peptides | 51 | 11 | 0 |
https://bachem.com/ | 46 | 10 | 0 |
https://phoenixpeptide.com/product_category/peptides/ | 64 | 9 | 0 |
https://biotechpeptides.com/ | 46 | 9 | 0 |
These pages were selected because they relate to the company in the captured answers. Their current contents still need checking before any correction request. A page linked to a conflicting claim is not necessarily its cause, and the same answer may contribute to more than one row.
The cited pages selected for review are mostly third-party industry sites and competitor domains, with a few AminoVault pages. Citation counts show these sources appear in answers that mention the company, but they do not show that any page caused a mention or a recommendation. The agency would review each page's current content before proposing anything.
Requests to publishers would be limited to specific, evidence-backed corrections or additions, and framed as requests rather than expectations. Where a page is a competitor's own site, outreach is unlikely to be productive; the agency would note that and focus effort on sources the client can realistically influence.
Step 4. Optimize priority company pages
Questions This Section Answers
- Which observed AminoVault website pages should receive review briefs?
Company website page | Citation appearances in all captured answers | Benchmark answers citing the page | Recommending answers citing the page |
|---|---|---|---|
https://aminovault.com/ | 18 | 18 | 15 |
https://aminovault.com/top-research-peptide-companies-usa/ | 5 | 5 | 2 |
https://aminovault.com/best-peptide-sites/ | 3 | 3 | 1 |
https://aminovault.com/?srsltid=AfmBOoqQWaIuSpJCHucB0bab0GgHW4p4FfCT08uzUZuu_JzuyUbFPX_S | 1 | 1 | 0 |
The company's website was cited 27 times across 4 distinct page addresses; the table shows 4 pages selected for review. Zeros in the answer columns mean no matching answers were recorded. A cited page is not automatically a page that accompanied a recommendation.
The homepage carries most of the citations, with a few category and list pages contributing smaller numbers. That concentration is useful: the homepage is doing the heavy lifting, while the supporting pages are lightly referenced. The agency would brief improvements to the homepage first and treat the other pages as secondary.
Page briefs would use approved facts and the buyer questions observed in the research, not assumptions about what a page currently says. Each brief would specify the audience question it answers and the evidence behind each claim. A cited page is not automatically a page that accompanied a recommendation, so the briefs would be judged on clarity and accuracy rather than citation counts alone.
Step 5. Publish around buyer questions
Questions This Section Answers
- Which observed buyer questions support content briefs for AminoVault?
Question observed in the research | Benchmark answers to this question | Company mentions | Company recommendations |
|---|---|---|---|
What is the best peptide company? | 3 | 2 | 2 |
Who makes research peptides in the US? | 3 | 2 | 2 |
top peptide companies | 2 | 2 | 2 |
Who is the most reputable peptide supplier? | 3 | 2 | 1 |
What are the best peptide companies in the US? | 4 | 1 | 1 |
What is the #1 peptide company? | 3 | 1 | 1 |
What is the best peptide brand? | 2 | 1 | 1 |
What is the best peptide company in the US? | 5 | 1 | 1 |
These are recorded answer observations, not search volume, verified demand, or proof of missing website content.
The observed questions cluster around choosing a supplier, US-based research peptides and reputation. AminoVault appears in answers to most of them, which suggests the brand is already part of the consideration set for these buyer questions. The counts are recorded answer observations, not search volume or verified demand.
The agency would check existing coverage before proposing new pages, then draft briefs that answer these questions directly with approved facts. Priority would go to the questions where the brand appears but is recommended less often, since those are the clearest opportunities to strengthen an existing position.
Our 90-day action plan
Questions This Section Answers
- How should the agency sequence the proposed AminoVault work and judge completion?
Period | Deliverable | Completion criterion |
|---|---|---|
Days 1–30 | Baseline scorecard, scoped fact-review register and page/source shortlist | Each record has an owner, evidence requirement and review status |
Days 31–60 | Approved page briefs and justified publisher requests | Separate confirmed edits, no-change decisions, requests and responses |
Days 61–90 | Buyer-content briefs and a fresh scorecard | Record work completed separately from measured answer outcomes and comparability limits |
The first month establishes the baseline scorecard, a scoped fact-review list and a shortlist of pages and sources, each with an owner and review status. The second month turns approved facts into page briefs and justified publisher requests, with confirmed edits, no-change decisions and responses recorded separately.
The third month adds buyer-question content briefs and a fresh scorecard. Completed work would be reported separately from measured answer outcomes, and no gain would be claimed until a comparable edition confirms it. Reviewers would sign off on facts before any brief or request leaves the agency.
Methodology
Questions This Section Answers
- How are AminoVault answer metrics and citation populations defined?
This report covers 2026-11. The exact dates when the original AI answers were collected have not been verified. The visibility rates use 453 answers that met the benchmark's inclusion rules. A company is recommended only when the answer both endorses it and uses positive wording. Top 3 and first-place counts are part of those recommendations, not extra recommendations.
An answer can mention or recommend several companies, so company counts cannot be added to find the number of distinct answers. The net sentiment score is positive minus negative mentions, divided by all company mentions; it describes answer wording, not customer satisfaction.
The wider citation analysis covers 554 captured answers and 3581 appearances of cited URLs. Citation appearances across all captured answers differ from the number of benchmark answers citing a page and the number that also recommend a company. The current contents of cited pages and disputed company claims still need independent verification.
Monthly sample coverage:
Reporting month | Answers included | AI services covered | Services |
|---|---|---|---|
Nov 2026 | 453 | 6 | ChatGPT, Copilot, Gemini, Google AI Mode, Google AI Overviews, Perplexity |
Earlier editions (July 2026, August 2026, September 2026 and October 2026) used a narrower set of questions. This edition includes all captured answers screened as relevant and establishes a broader baseline. Earlier figures remain in the archive; they are not used to claim a change in performance.
Future editions using the same screening scope can be compared against this baseline.
The answers were captured without verified collection dates, and the visibility rates rest on the answers that met the benchmark's inclusion rules. A company counts as recommended only when an answer endorses it with positive wording; top-three and first-place counts sit inside those recommendations rather than adding to them.
Answers can mention several companies, so company counts do not sum to distinct answers. Citation appearances across all captured answers differ from benchmark answers citing a page. Cited pages and disputed claims still need independent verification, and this edition's broader question scope makes it a baseline rather than a trend.
Our first three priorities
First, confirm the company's core facts against primary sources so any later page brief or publisher request rests on verified ground. Second, brief the homepage and the small set of supporting pages around the buyer questions where AminoVault already appears, using approved facts and clear answers rather than citation chasing.
Third, review the selected third-party sources and prepare only specific, evidence-backed requests where a genuine gap exists. Throughout, the agency would keep completed work separate from measured visibility and wait for a comparable edition before drawing conclusions about progress.
Related research
This report supports CiteWorks Studio's examination of how AI search is recommending Peptide Suppliers. For more detail, you can also read Peptide Suppliers: AI Visibility Discovery Index.
/ Learn More
Understanding AI search visibility.
AI search experiences create answers by pulling information from many places online and summarizing it into a single response.


